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Abstract
Background: Night-time calf cramping affects approximately 1 in 3 adults. The aim of this study was to explore
the experience of night-time calf cramp; if and where people seek treatment advice; and perceived treatment
effectiveness.
Methods: 80 adults who experienced night-time calf cramp at least once per week were recruited from the
Hunter region, NSW, Australia through newspaper, radio and television advertisements. All participants completed a
pilot-tested survey about muscle cramp. Quantitative data were analysed with independent-sample t-tests, Chi
square tests and Fisher’s tests. Qualitative data were transcribed and sorted into categories to identify themes.
Results: Median recalled age of first night-time calf cramp was 50 years. Most participants recalled being awoken from
sleep by cramping, and experiencing cramping of either calf muscle, calf-muscle soreness in the days following cramp
and cramping during day-time. Despite current therapies, mean usual pain intensity was 66 mm on a 100 mm visual
analogue scale. Participants described their cramps as being ‘unbearable’, ‘unmanageable’ and ‘cruel’. One participant
stated that ‘sometimes I just wish I could cut my legs open’ and another reported ‘getting about 2 h sleep a night due to
cramps’. Most participants had sought advice about their night-time calf cramps from a health professional. Participants
identified 49 different interventions used to prevent night-time calf cramp. Of all treatment ratings, 68% described the
intervention used to prevent cramp as being ‘useless’ or of ‘al i t t l eh e l p ’. Of 14 participants who provided additional
information regarding their use of quinine, eight had a current prescription of quinine for muscle cramp at the time of
the survey. None had been asked by their prescribing doctor to stop using quinine.
Conclusion: Night time calf cramps typically woke sufferers from sleep, affected either leg and caused ongoing
pain. Most participants experienced little or no relief with current therapies used to prevent muscle cramp. Most
people who were taking quinine for muscle cramp were unaware that the Australian Therapeutic Goods
Administration withdrew support of quinine for muscle cramp in 2004 due to the risk of thrombocytopaenia. Case-
control studies are required to identify therapeutic targets so that clinical trials can evaluate safe interventions to
prevent recurrent cramp.
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Background
Muscle cramps are sudden, involuntary, painful contrac-
tions of skeletal muscle [1,2]. They are characterised
electrically by repetitive firing of motor unit action
potentials at rates up to 150 per second [3], more than
four times the usual rate in maximum voluntary con-
traction [4]. Approximately 1 in 3 adults experience
night-time cramping of the calf-muscle [5], the most
common type and location of cramp [6-8]. Despite the
high prevalence of night-time calf-muscle cramps, it is
not well understood why some people cramp and others
do not. Currently, many interventions are available for
preventing night-time calf-muscle cramps (e.g. quinine,
magnesium, and muscle stretching, strengthening and
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[10] has demonstrated adequate efficacy and safety. No
drug therapy is currently approved under the Australian
Pharmaceutical Benefits Scheme (PBS) [11] for muscle
cramps. In 2004, the Australian Therapeutic Goods
Administration (TGA) withdrew approval of quinine
sulphate or bisulphate tablets (Quinate or Quinbisul) for
muscle cramps due to the risk of thrombocytopenia
(decreased platelet count) [12]. Quinine is now a
streamlined authority PBS item, subsidised only for use
in malaria, and doctors are encouraged by the TGA to
ask patients to stop taking quinine for muscle cramp
[13].
Management of leg cramps has been described as
being frustrating [14] and difficult [15]for clinicians and
patients alike. It has been suggested that many people
experience no benefit from the treatments prescribed
[3,7,16] and many more receive no treatment at all
[5,7,15], however these assertions have not been
evaluated.
The aim of this study was to explore: (1) the experi-
ence of night-time calf cramp; (2) if and where people
seek treatment advice; and (3) perceived treatment
effectiveness.
Method
Adults who experienced night-time calf cramp at least
once per week in the preceding three months volun-
teered to participate between August 2010 and March
2011. Muscle cramp was described as ’a sudden, invo-
luntary and painful contraction of muscle that gradually
lessens. During cramp, the affected muscle hardens and
joints can be forced into unusual positions. In some peo-
ple, cramp can be brought on by certain movements
and/or stopped by stretching the muscle’.T h i sd e f i n i t i o n
was based on descriptions reported in the literature
[1,2,17] and on clinical experience in describing cramp-
ing to patients. Exclusion criteria were: dementia, lower
limb injury, and conditions known to cause cramps
(including, neuromuscular or neurological disease, preg-
nancy; and haemodialysis). No exclusions were made
based on medication use or current treatment of
cramps. All participants were proficient in English and
ambulant. Participants were recruited from the Newcas-
tle, Central Coast and Hunter Valley regions of NSW,
Australia. The study was promoted: on regional televi-
sion news and radio; in four regional newspapers; in
reception areas of a podiatry practice, University clinic
and local General Practice, and by contacting local com-
munity groups (e.g. Lions and Rotary Clubs). The
research was promoted as an investigation of the cause
of muscle cramp. This limited the potential recruitment
of people with conflicts of interest (e.g. people affiliated
with companies selling treatments for night cramps).
Interested community members contacted the principal
investigator (F.B.) by phone. All participants consented
to participate in accordance with the University of New-
castle Human Research Ethics Committee.
No validated surveys are available for night-time mus-
cle cramping. Prior to commencing the research, a
bespoke survey was developed and pilot-tested for con-
tent validity by four health professionals with experience
in treating night-time muscle cramp, by two patients
who experience night-time calf cramp and by two other
non-health professionals. During pilot testing each parti-
cipant was asked to identify any ambiguous questions or
statements and to suggest additional questions. Some
minor amendments to technical language were made to
produce the final survey. The survey comprised ques-
tions covering: gender; age; family history of night-time
cramp; age of cramp onset; leg/s affected; timing of
cramps; usual pain severity of cramp (rated on a 100
mm visual analogue scale where 0 = no pain and 100 =
worst pain imaginable); cramp frequency; presence of
calf pain during the day/s after cramp; consistency of
the pattern of cramping; whether advice had been
sought regarding night-time calf cramp (if so, from
whom, and the effectiveness of recommended treat-
ments); other treatments tried; whether muscles other
than the calf cramp at night (if so, which muscles); and
whether muscle cramp also occurs during the day (if so,
which muscles and when). Participants were also given
the opportunity to add comments about the interven-
tions used and were asked the question: ‘What do you
think causes your cramps?’ A survey was posted to each
participant and returned by post or in-person to one of
the clinics promoting the research. Participants who
reported having used quinine for night-time calf cramps
were followed up to check whether or not they were
still using quinine for cramps. Participants who were
still using quinine were asked how often they take it, if
the prescribing doctor was a general practitioner, and if
their prescribing doctor had: (1) asked them to stop tak-
ing quinine, (2) explained that quinine was no longer
approved under the PBS for muscle cramp; (3) discussed
the possible adverse effects of quinine.
Quantitative data were analysed using SPSS v.19 (Chi-
cago, IL, USA) to produce descriptive statistics. Contin-
uous data were tested for normality using the
Kolmogorov-Smirnov test. The non-normally variable
‘age at cramp onset’ was described using median and
interquartile range (IQR) and was transformed to nor-
mal distribution for inferential statistical analysis using
the formula reflect and square root insert [18]. Statisti-
cal significance of between-group differences were tested
with independent-sample t-tests for continuous data and
either Chi-square analysis (with Yates Continuity Cor-
rection for 2 by 2 tables) or Fisher’s exact test (if a cell
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mous data. Responses to the question ‘What do you
think causes your cramps’ were transcribed and sorted
into mutually exclusive and exhaustive categories using
emergent coding [19].
Results
Eighty-three potential participants were sent an informa-
tion sheet, consent form and survey. Eighty people (47
females and 33 males) volunteered to participate and
completed the survey. Age ranged from 37 to 93 years
(mean 71; standard deviation [SD] 10). Of the three peo-
ple who did not return the survey, one ‘decided against
it’, one could not find the time, and one did not respond
to follow up phone calls and emails.
Description of the night-time calf cramps
The usual pain intensity of night-time calf cramp rated
on a 100 mm visual analogue scale ranged 29 mm to
100 mm (mean 66; SD 19). There was no statistically
significant difference in usual pain intensity of night-
time calf cramp between men and women (63 mm vs.
69 mm; mean difference -6 mm; 95%CI: -15 to 2; t77 =
-1.43; p = 0.16), or between younger (≤ 64 years, n =
15) and older ( ≥ 65 years, n = 64) people (69 mm vs.
66 mm; mean difference 3 mm; 95%CI: -7 to 15; t77 =
0.69; p = 0. 49. Recalled age of first night-time calf
cramp ranged from 9 to 85 years (median 50; IQR 35).
26% of participants reported a known family history of
night-time leg cramps.
Of the 74 participants who could recall when cramps
typically begin, 45 (61%) recalled usually being asleep
when cramps begin. Seventy one (89%) participants
reported that cramp could affect either leg. Cramps
were mostly reported to occur at irregular times
throughout the night (n = 32, 40%), during the middle
of sleeping time (n = 24, 30%), within two hours of ris-
ing in the morning (n = 10, 12.5%), before falling asleep
(n = 6, 7.5%) and within two hours of first falling asleep
(n = 6, 7.5%). Two participants (2.5%) were unsure of
cramp timing. Calf-muscle soreness or tenderness in the
days following cramp was reported to occur sometimes
by 32 (40%) participants, most of the time or always by
25 (32%) participants and never or rarely by 22 (28%)
participants. People who most of the time or always
experienced pain during the days following cramp were
more likely than people who never, rarely or sometimes
experienced pain during the days following cramp to
have experienced more intensely painful night-time calf
cramp (75 mm vs. 63 mm; mean difference 12 mm; 95%
CI: 3 to 21; t77 = 2.7; p = 0.008), but were no older (n =
15) or younger (n = 64) (t77 = 0.69; p = 0.49).
Thirty-three percent of participants reported experien-
cing night-time calf cramp most nights per week.
Between people who experience calf cramp ≤ 3n i g h t s
per week and people who experience calf cramp most
nights per week, there was no statistically significant dif-
ference in mean usual pain intensity of night-time calf
cramp (65 mm vs. 75 mm; mean difference -10 mm;
95%CI: -23 to 2; t77 = -1.6; p = 0. 11) or mean age (71
years vs. 75 years; mean difference -4 years; 95%CI: -11
to 2; t77;- 1 . 3 8 ;p = 0. 17). 63% of participants reported
frequency of night-time calf cramp as being inconsistent.
Sixty-eight (85%) participants also reported experien-
cing night cramp in muscles other than the calf. 61
(76%) participants reported experiencing muscle cramp
during the day while awake. Locations of night and day
cramps are listed in Table 1. Participants who experi-
enced day time muscle cramp were no more likely to
experience night-time muscle cramp of muscles other
than the calf (p = 0.68, Fisher’s exact test) and partici-
pants who experienced day time calf cramp were no
more likely to experience more frequent night-time calf
cramp (p =0 . 5 0 ,F i s h e r ’s exact test). Day cramps were
reported to occur: at rest while sitting (n = 44, 72%);
while lying down (n = 23, 38%); during physical activity
other than walking or climbing stairs (n = 21, 34%);
while standing (n = 14, 23%); while walking (n = 9,
15%); while climbing stairs (n = 4, 7%); and at other
times (n = 7, 11%).
Treatment advice
Sixty of the 80 participants had sought advice about
their night-time calf cramps. All reported sources of
advice are listed in Table 2. All 10 participants who
reported cramping most nights per week had sought
advice, but the difference to those who reported cramp-
ing three or less night per week was not statistically sig-
nificant (100% vs. 71%; Fisher’s Exact Test p=0.58).
Cramp pain intensity was not associated with seeking
advice (t77 = 0.58; p = 0.56) and women were no more
likely than men to have sought advice about their night-
time calf cramp from any source (c
2 [1, n = 80] = 1.4, p
= 0.24, phi = 0.16). Participants who had sought advice
were six years older on average than those who had not
(73 years vs. 67 years; mean difference 6 years; 95% CI:
1t o1 1 ;t78 = -2.45; p = 0.02). Participants who had
sought advice about their night-time calf cramp over the
internet were 13 years younger on average than people
who had not (61 vs. 74 years; mean difference 13 years;
95%CI: 4 to 22; t58 = 2.78; p = 0.007).
All participants had tried to treat their night-time calf
muscle cramps. All reported interventions and ratings of
perceived effectiveness are listed in Table 3. Only two
participants rated a treatment used to prevent cramp as
being 100% effective (both ratings for quinine). Of all
197 ratings of preventative interventions, 132 (67%)
described the interventions as being ‘useless’ or ‘a little
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tions as being very helpful or 100% effective. Nine of
these 19 ratings were for quinine. Overall, interventions
used during cramp were perceived as being more effec-
tive than interventions used to prevent cramp.
Participants who had used quinine for muscle cramp
(n = 18) were more likely than people who had not
used quinine for muscle cramp to experience more fre-
quent night-time calf cramp (28% ≥ 4 night per week vs.
8% ≥ 4 night per week p =0 . 0 4 ,F i s h e r se x a c tt e s t )b u t
were no more likely to: be female (61% vs. 58%, c
2 [1, n
=8 0 ]=0 . 0 0 ,p = 1.00, phi = 0.03); be older (mean 74
years vs. 70 years, t78 = -1.59; p =0 . 1 2 ) ;e x p e r i e n c e
more painful night-time calf cramp (mean 67 mm vs. 66
mm, t77 = -0.23; p = 0. 82); and have earlier onset of
night-time calf cramp (mean 45 years vs. 49 years, t =
[71] = 0.63; p = 0. 53).
Use of quinine
Of the 18 participants who reported having used qui-
nine for night-time calf cramp, 14 responded to a follow
up telephone call to provide more information. Six par-
ticipants had stopped taking quinine between 18 months
and 8 years ago. Of these, three participants were
advised by their General Practitioner (GP) to stop using
quinine due to safety concerns. Of the remaining three,
o n ew a sn o t i f i e do ft h ea s s o c i a t e dr i s k sb yac h e m i s t ,
one stopped experiencing cramps so discontinued using
quinine, and one discontinued taking quinine to try a
non-prescription treatment.
Eight participants reported current use of quinine for
cramps. All eight received prescription from their GP.
Three reported taking quinine daily, one reported taking
quinine every second night, and four reported taking
quinine only when cramps were particularly bad, ran-
ging from ‘once or twice a week’ to ‘once per month, on
average’. None of the eight had been asked by their GP
to stop taking quinine. Only two had been told by their
GP that quinine was not covered under the PBS. Six
participants could not recall being notified of possible
adverse effects by their GP. Of the other two, one
r e p o r t e db e i n gt o l dt h a ti tc o u l d‘affect the heart’,a n d
one recalled being told that quinine wasn’tg o o df o r
him, but the participant was not sure why.
Qualitative data
Of the 62 participants who responded to the open-
ended question ‘What do you think causes your
cramps?’ 2 0r e s p o n d e dt h a tt h e yd i dn o tk n o w .E l e v e n
participants thought cramps could be due to the posi-
tion in which they sleep and movements from this posi-
tion (for example, ‘if I straighten my legs quickly’). One
participant reported a cramp triggered by an event in a
dream where they suddenly needed to run. Nine partici-
pants thought that cramps could be due to poor circula-
tion to the lower limbs. Five participants thought
cramps could be due to unusually high levels of physical
Table 1 Location of night and day time cramping
Location of cramp During the night, n of participants While awake during the day, n of participants
Calf 80 37
Foot 49 32
Front of lower leg 28 8
Hand 25 32
Inner thigh 25 14
Back of thigh 23 13
Front of thigh 16 5
Arm 9 7
Buttock 4 1
Other 10 11
Table 2 Sources of advice
Number of
participants
General practitioner 51
Pharmacist 14
Podiatrist 8
Medical specialist 7
Family member or friend who is not a health
professional
6
Physiotherapist 5
Naturopath 5
Internet 4
Chiropractor 3
Traditional Chinese Medicine practitioner 2
Bowen therapist 1
Massage therapist 1
Health food herbalist 1
Health food shop assistant 1
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Intervention Number of
users
Perceived effectiveness
Useless A little
help
Quite
helpful
Very
helpful
100%
effective
Unrated
During cramp to reduce pain
Getting out of bed to stand or walk* 77 4 21 19 27 5 1
Stretching calf* 75 20 22 20 12 1
Massage* 69 6 42 13 7 1
Heat application 4 3 1
Running on the spot 1 1
To prevent cramp
Magnesium 46 12 16 11 5 2
Water, drinking more* 36 11 19 5 1
Stretching calf during day or before bed* 24 7 11 2 1 3
Massage during day* 21 5 11 5
Quinine 18 1 1 7 7 2
Crampeze tablet/capsule 13 5 6 2
Tonic water 5 1 2 2
Gatorade/poweraid 4 1 3
Salt 3 1 2
Crampeze cream 2 1 1
Vitamin B 2 1 1
Akineton (biperiden) 21 1
Hamstring stretching 2 1 1
Lyrica (pregabalin) 11
Schuessler tissue salts (homeopathic
preparation)
11
Camphor in bed 1 1
Cramp away (homeopathic preparation) 1 1
Exercise and stretching with personal trainer 1 1
Filtered water 1 1
Homeopathic drops containing ginkgo 1 1
Iron tablets 1 1
Japanese green tea 1 1
Acupuncture 1 1
Calcium 1 1
Epsom salt bath 1 1
Glucosamine 1 1
Minerals 1 1
Panadol osteo 1 1
Tegretol (carbamazepine) 11
Shaking of legs during shower 1 1
Aspirin 1 1
Fish oil 1 1
Mandopar (levodopa and benserazide))1 1
Multi vitamins 1 1
Potassium 1 1
Vitamin E 1 1
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cramp could also be due to unusually low levels of activ-
ity. Another participant suggested night cramp was due
to holding legs in ‘one cramped position’ on a bus trip
during the day. Four participants thought that cramp
could be due to lack of salt. One participant added ‘a
doctor said this 25 years ago’.
Three participants associated night cramp with noc-
turia, but disagreed as to whether cramp was caused by
‘a full bladder’, or moving the legs on waking. Two par-
ticipants thought cramps could be due to ‘lack of water’,
or ‘dehydration’. Other suggestions included ‘uric acid’,
‘age’, ‘tiredness’, ‘cold’, ‘hereditary’, ‘after IV chemother-
apy’, ‘night sweats’, ‘hypoglycaemia’, ‘chocolate’, ‘alcohol’,
‘peripheral neuropathy’, ‘some connection with the per-
ception of cold’ or ‘another nasty complication of my
diabetes’. One participant commented that cramps
‘started when I moved from England at 67 [years of age]’
and are ‘worse in summer after playing bowls’.A n o t h e r
participant, after stating that she had ‘no idea’ what
causes the cramps, commented ‘it is cruel. Sometimes I
just wish I could cut my legs open’.C r a m p sw e r e
described as ‘unbearable’ and ‘unmanageable’. One parti-
cipant stated they were ‘getting about 2 h sleep a night
due to cramps’ and another said that they ‘can’td oa n y -
thing after cramps due to fear of getting another one’.
Discussion
Most participants recalled being awoken from sleep by
cramps and cramps occurring at irregular times or in
the middle of sleeping time. These findings suggest that
night-time muscle cramping may profoundly affect qual-
ity of sleep. Most participants also reported experiencing
calf-muscle soreness in the days following cramp. There
are anecdotal reports in the literature of discomfort per-
sisting for hours following night-time muscle cramp
[15]. This is the first study to demonstrate the preva-
lence and lengthy duration of ongoing pain.
Mean usual pain intensity of night-time calf cramp
was 66 mm on a 100 mm visual analogue scale and
most participants also experienced night-time muscle
cramping of other muscles and day time muscle cramp-
ing. The severity and high frequency of cramps reported
by participants are despite current therapies. As most
participants reported experiencing some help from treat-
ment, it is expected that frequency and severity of
cramp would be higher if current treatments were
withdrawn.
Median reported age of first cramp (50 years) in this
sample was younger than previous reports in the litera-
ture. Of 86 respondents to a United Kingdom (UK)
postal survey who reported suffering from rest cramps,
the mean age of cramp onset was 60 years (95%CI: 57
to 63) [15]. This result is reflected by a second UK sur-
vey of 182 people over 65 years of age who experienced
leg muscle cramp. 80% of participants reported cramp
onset after 55 years of age [7]. The younger age of
cramp onset in the present sample might reflect the
inclusion of adults of all ages or differences in exposure
to cramp precipitants (e.g. climate) between the UK and
Australia. Indeed one participant stated that cramps
‘started when I moved from England at 67 [years of
age]’, although this could be coincidental.
Advice-seeking behaviour in our sample was more
common than in previous reports in the literature. In a
UK survey of 182 people over 65 years of age who
experienced leg muscle cramp, only 40% sought advice
from their General Practitioner about their cramp (con-
trast to 63% in our sample) [7]. This is similar to the
results of a similar survey in England of people ran-
domly selected from a General Practitioner’sR e g i s t e r
[15]. Interestingly, of all participants who had not
reported cramp to a General Practitioner, 31% described
their cramps as being very distressing or a major nui-
sance [15]. Despite the present finding of more common
advice seeking, only two participants reported achieving
cramp prevention with treatments recommended. Both
reports related to quinine, which doctors in Australia
are now discouraged from prescribing for muscle
cramps.
T h em o s tc o m m o n l yr e p o r t e d treatment used to pre-
vent recurrent cramp was magnesium supplementation
(used by 58% of participants). Most participants per-
ceived the magnesium supplements as being ‘useless’ or
only ‘a little help’. This is consistent with randomised
trials that found that, while magnesium supplementation
Table 3 Reported interventions and perceived effectiveness (Continued)
Vitamins 1 1
Zinc 1 1
Bananas 1 1
Oranges 1 1
*Participants were asked whether they had tried interventions identified with an asterisk. Non-asterisked interventions were identified by participants when asked
whether they had tried any other interventions
Interventions are ordered from most to least commonly reported. Where a particular treatment is reported as commonly as another, interventions are ordered
from perceived most to least effective, then in alphabetical order.
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pregnancy [20], it is no more effective than placebo for
night-time cramp [21] or chronic persistent leg cramp
[17]. The effectiveness of magnesium for skeletal muscle
cramps is currently being reviewed under the Cochrane
Neuromuscular Disease Group [22].
Interestingly, in the trial of magnesium citrate for
chronic persistent leg cramps [17], about half of people
allocated to the placebo group perceived that placebo
had helped. For all interventions reported in the present
study, it is not possible to disentangle any placebo effect
from true intervention effects. It is possible that the pla-
cebo effect accounts for some, if not all, of the perceived
effectiveness of some interventions.
Interpretation of some findings is constrained by lim-
itations of the survey. For example, people who reported
stretching the calf muscles were not asked to demon-
strate how they performed the stretch. On discussion
with some participants, it became clear that some
stretching techniques were inappropriate, for example,
actively plantarflexing the foot to stretch the calf muscle.
While this limits the interpretability of effectiveness rat-
ings for calf stretching in this survey, it clearly demon-
strates the need for health practitioners to carefully
demonstrate and check stretching techniques when
advising their patients to stretch. A second limitation of
the survey is the potential for recall bias when nominat-
ing interventions used now and in the past. Participants
were asked to list all interventions that they had used
for night-time muscle cramp. In addition, participants
were specifically asked whether they had used certain
interventions. These are marked with asterisks in Table
3. Direct questioning may have improved recall and led
to an increased response rate for these interventions.
The most commonly suggested cause of cramp was
sleeping position and movements from this position.
Participants who identified the particular movements
that induced cramp described plantarflexion of the
ankle joint as the trigger. To prevent calf cramp, one
participant described sleeping with a foot board at the
base of their bed to prevent ankle joint plantarflexion
and others described actively dorsiflexing the ankle joint
when the early symptoms of cramp appeared. Avoidance
of ankle plantarflexion has been described in the litera-
ture as a potential treatment to prevent recurrent cramp
[23-26]. Suggestions include using pillows [25,27] or a
foot board [24] to resist ankle plantarflexion, and sleep-
ing prone with feet overhanging the end of the bed [24].
None of these approaches have been evaluated in clini-
cal trials and some might not be practical due to pro-
pensity to reposition during sleep [27]. Use of a
dorsiflexion night-splint would offer a more controlled
and sustained dorsiflexion, yet this has not been evalu-
ated or even suggested, to our knowledge.
Conclusions
Night time calf cramps typically awoke sufferers from
sleep, affected either leg and caused ongoing pain. Most
participants experienced little or no relief with current
therapies used to prevent muscle cramp. Most people
who were taking quinine for muscle cramp were una-
ware that the Australian Therapeutic Goods Administra-
tion withdrew support of quinine for muscle cramp in
2004 due to the risk of thrombocytopaenia. Case-control
studies are required to identify therapeutic targets so
that clinical trials can evaluate safe interventions to pre-
vent recurrent cramp.
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